BioPharma Credit PLC
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.8298
- Today's High:
- $0.8298
- Open Price:
- $0.8298
- 52W Low:
- $0.9
- 52W High:
- $1
- Prev. Close:
- $0.87
- Volume:
- 13186
Company Statistics
- Market Cap.:
- $1.27 billion
- Book Value:
- 1.014
- Revenue TTM:
- $218.17 million
- Operating Margin TTM:
- 83.58%
- Gross Profit TTM:
- $103.88 million
- Profit Margin:
- 83.56%
- Return on Assets TTM:
- 8.34%
- Return on Equity TTM:
- 13.5%
Company Profile
BioPharma Credit PLC had its IPO on under the ticker symbol BOPCF.
The company operates in the sector and industry. BioPharma Credit PLC has a staff strength of 0 employees.
Stock update
Shares of BioPharma Credit PLC opened at $0.83 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.83 - $0.83, and closed at $0.83.
This is a -4.62% slip from the previous day's closing price.
A total volume of 13,186 shares were traded at the close of the day’s session.
In the last one week, shares of BioPharma Credit PLC have slipped by -4.62%.
BioPharma Credit PLC's Key Ratios
BioPharma Credit PLC has a market cap of $1.27 billion, indicating a price to book ratio of 0 and a price to sales ratio of 10.6251.
In the last 12-months BioPharma Credit PLC’s revenue was $218.17 million with a gross profit of $103.88 million and an EBITDA of $0. The EBITDA ratio measures BioPharma Credit PLC's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, BioPharma Credit PLC’s operating margin was 83.58% while its return on assets stood at 8.34% with a return of equity of 13.5%.
In Q2, BioPharma Credit PLC’s quarterly earnings growth was a positive 184.5% while revenue growth was a positive 174.1%.
BioPharma Credit PLC’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 14.6774
- PEG
Its diluted EPS in the last 12-months stands at $0.062 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into BioPharma Credit PLC’s profitability.
BioPharma Credit PLC stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 10.6251.
BioPharma Credit PLC stock pays annual dividends of $0.07 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $0
- Total Liabilities
- $4.00 million
- Operating Cash Flow
- $-29453500.00
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
BioPharma Credit PLC ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.
BioPharma Credit PLC ended 2024 with $0 in deferred long-term liabilities, $4.00 million in other current liabilities, 13739000.00 in common stock, $762.93 million in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
BioPharma Credit PLC’s total current assets stands at $56.32 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $45.88 million compared to accounts payable of $0 and inventory worth $0.
In 2024, BioPharma Credit PLC's operating cash flow was $-29453500.00 while its capital expenditure stood at $0.
Comparatively, BioPharma Credit PLC paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.83
- 52-Week High
- $1
- 52-Week Low
- $0.9
- Analyst Target Price
- $
BioPharma Credit PLC stock is currently trading at $0.83 per share. It touched a 52-week high of $1 and a 52-week low of $1. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.9 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 769.4% of the company’s stock are held by insiders while 3921.6% are held by institutions.
Frequently Asked Questions About BioPharma Credit PLC
Most Active
Top Gainers
Top Losers
About
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in London, the United Kingdom.